Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Japanese Phase 2 Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)

NCT04533581 is registered in ClinicalTrials.gov with Kyowa Kirin Co., Ltd. as lead sponsor.

NCT NCT04533581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04533581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Japanese Phase 2 Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)
Lead sponsor
Kyowa Kirin Co., Ltd.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 17, 2020
Completion date
May 31, 2028
Enrollment
61 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

indolent b-cell non-hodgkin's lymphoma